Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.31 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.31 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.31 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.31 |
| ▸ | HTR2B | P41595 | 1/20 | 0.31 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL392238 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL29556368 | 0.78 | TSHR (0.34) | TSHRFAAHCA1CA2LMNA | |
| Hydrochloric Acid SCHEMBL715702 | 0.77 | GABRA1 (0.33) | TSHRFAAHCA1CA2LMNA | |
| Hydrochloric Acid SCHEMBL4461086 | 0.73 | CA4 (0.30) | — | |
| Hydrochloric Acid SCHEMBL3615425 | 0.71 | MEN1 (0.33) | TSHR | |
| Hydrochloric Acid SCHEMBL4449806 | 0.71 | TSHR (0.31) | TSHRFAAHCA1CA2LMNA | |
| Hydrochloric Acid SCHEMBL4232392 | 0.69 | GABRA1 (0.44) | TSHRFAAHCA1CA2LMNA | |
| SCHEMBL5709976 | 0.69 | FAAH (0.32) | TSHRFAAHCA1CA2LMNA | |
| Hydrochloric Acid SCHEMBL30697857 | 0.68 | GABRA1 (0.36) | TSHRFAAHCA1CA2LMNA | |
| Hydrochloric Acid SCHEMBL4449809 | 0.68 | GABRA1 (0.32) | TSHRFAAHCA1CA2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8431659-B2 | Prepolymerized catalyst for olefin polymerization, method of producing this prepolymerized catalyst and method of producing olefin polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-04-30 | — | — | US | disclosed |
| US-20120095173-A1 | PREPOLYMERIZED CATALYST FOR OLEFIN POLYMERIZATION, METHOD OF PRODUCING THIS PREPOLYMERIZED CATALYST AND METHOD OF PRODUCING OLEFIN POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-04-19 | — | — | US | disclosed |
| US-8101537-B2 | Prepolymerized catalyst for olefin polymerization, method of producing this prepolymerized catalyst and method of producing olefin polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-24 | — | — | US | disclosed |
| US-20100280196-A1 | PREPOLYMERIZED CATALYST FOR OLEFIN POLYMERIZATION, METHOD OF PRODUCING THIS PREPOLYMERIZED CATALYST AND METHOD OF PRODUCING OLEFIN POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-11-04 | — | — | US | disclosed |
| US-7211537-B2 | Modified aluminum oxy compound, polymerization catalyst and process for producing olefin polymer and alkenyl aromatic hydrocarbon polymer | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2007-05-01 | — | — | US | disclosed |
| US-20050197471-A1 | Modified aluminum oxy compound, polymerization catalyst and process for producing olefin polymer and alkenyl aromatic hydrocarbon polymer | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2005-09-08 | — | — | US | disclosed |
| US-6921800-B2 | Modified aluminum oxy compound, polymerization catalyst and process for producing olefin polymer and alkenyl | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-07-26 | — | — | US | disclosed |
| US-20040224838-A1 | Modified aluminum oxy compound, polymerization catalyst and process for producing olefin polymer and alkenyl aromatic hydrocarbon polymer | FUJITA MASAYUKI (JP) | 2004-11-11 | — | — | US | disclosed |
| US-6664208-B1 | For synthesis of highly stereoregular high molecular weight alphaolefin polymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-12-16 | — | — | US | disclosed |
| EP-0985673-A2 | Modified aluminium oxy compound, polymerization catalyst and process for producing olefin polymer and alkenyl aromatic hydrocarbon polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-03-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050197471-A1 | Modified aluminum oxy compound, polymerization catalyst and process for producing olefin polymer and alkenyl aromatic hydrocarbon polymer | AHR, ALOX5AP, ALOX15B | SLC6A2 3138/4885TSHR 4099/4885FAAH 323/4885 |
| US-20040224838-A1 | Modified aluminum oxy compound, polymerization catalyst and process for producing olefin polymer and alkenyl aromatic hydrocarbon polymer | AHR, ALOX5AP, ALOX15B | SLC6A2 3138/4885TSHR 4099/4885FAAH 323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.